150 related articles for article (PubMed ID: 34810213)
1. Concurrent Disruption of the Ras/MAPK and NF-κB Pathways Induces Circadian Deregulation and Hepatocarcinogenesis.
Hanley KL; Liang Y; Wang G; Lin X; Yang M; Karin M; Fu W; Feng GS
Mol Cancer Res; 2022 Mar; 20(3):337-349. PubMed ID: 34810213
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
[TBL] [Abstract][Full Text] [Related]
3. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation.
Sakurai T; Maeda S; Chang L; Karin M
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10544-51. PubMed ID: 16807293
[TBL] [Abstract][Full Text] [Related]
4. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
[TBL] [Abstract][Full Text] [Related]
5. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
[TBL] [Abstract][Full Text] [Related]
6. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
[TBL] [Abstract][Full Text] [Related]
7. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
8. Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment.
Chen WS; Liang Y; Zong M; Liu JJ; Kaneko K; Hanley KL; Zhang K; Feng GS
Cell Rep; 2021 Nov; 37(6):109974. PubMed ID: 34758313
[TBL] [Abstract][Full Text] [Related]
9. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of AEG-1 prevents hepatocarcinogenesis.
Robertson CL; Srivastava J; Siddiq A; Gredler R; Emdad L; Rajasekaran D; Akiel M; Shen XN; Guo C; Giashuddin S; Wang XY; Ghosh S; Subler MA; Windle JJ; Fisher PB; Sarkar D
Cancer Res; 2014 Nov; 74(21):6184-93. PubMed ID: 25193383
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
Sato Y; Kato J; Takimoto R; Takada K; Kawano Y; Miyanishi K; Kobune M; Sato Y; Takayama T; Matunaga T; Niitsu Y
Gut; 2006 Dec; 55(12):1801-8. PubMed ID: 16581947
[TBL] [Abstract][Full Text] [Related]
13. Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice.
Weng MC; Wang MH; Tsai JJ; Kuo YC; Liu YC; Hsu FT; Wang HE
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29535278
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of NF-κBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target.
Xu X; Lei Y; Chen L; Zhou H; Liu H; Jiang J; Yang Y; Wu B
J Exp Clin Cancer Res; 2021 Aug; 40(1):253. PubMed ID: 34380537
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
16. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8.
Lee EK; Kim DG; Kim JS; Yoon Y
Cancer Res; 2011 Nov; 71(21):6827-35. PubMed ID: 21917729
[TBL] [Abstract][Full Text] [Related]
17. Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling.
Chen L; Lin X; Lei Y; Xu X; Zhou Q; Chen Y; Liu H; Jiang J; Yang Y; Zheng F; Wu B
J Exp Clin Cancer Res; 2022 Nov; 41(1):329. PubMed ID: 36411480
[TBL] [Abstract][Full Text] [Related]
18. High expression levels of IKKalpha and IKKbeta are necessary for the malignant properties of liver cancer.
Jiang R; Xia Y; Li J; Deng L; Zhao L; Shi J; Wang X; Sun B
Int J Cancer; 2010 Mar; 126(5):1263-74. PubMed ID: 19728335
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction and ERK/NF-κB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo.
Tsai JJ; Chen JH; Chen CH; Chung JG; Hsu FT
Environ Toxicol; 2020 Feb; 35(2):167-175. PubMed ID: 31714653
[TBL] [Abstract][Full Text] [Related]
20. IGFBP2 upregulates ZEB1 expression and promotes hepatocellular carcinoma progression through NF-κB signaling pathway.
Guo Q; Yu DY; Yang ZF; Liu DY; Cao HQ; Liao XW
Dig Liver Dis; 2020 May; 52(5):573-581. PubMed ID: 31818638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]